ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2011

Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.

Mitchell HoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.